Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-20-023324
Filing Date
2020-12-10
Accepted
2020-12-10 21:50:26
Documents
2
Period of Report
2020-12-10

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2843
2 ex24.htm EX-24 9612
  Complete submission text file 0001493152-20-023324.txt   13929
Mailing Address C/O BIOPHARMX CORPORATION 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address
Krammer Anja B (Reporting) CIK: 0001418077 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39796 | Film No.: 201382072

Mailing Address 605 W.KNOX RD., SUITE 102 TEMPE AZ 85284
Business Address 605 W.KNOX RD., SUITE 102 TEMPE AZ 85284 (480)567-9787
Vivos Therapeutics, Inc. (Issuer) CIK: 0001716166 (see all company filings)

EIN.: 813224056 | State of Incorp.: WY | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus